Alkermes

Yahoo Finance • 10 days ago

ALKERMES PLC (NASDAQ:ALKS) Emerges as a Top Value Pick with Strong Fundamentals and Undervalued Metrics

ALKERMES PLC (NASDAQ:ALKS [https://www.chartmill.com/stock/quote/ALKS]) has been recognized as a possible choice for value investors using a "Decent Value" screening method. This approach targets stocks with solid fundamental valuations, s... Full story

Yahoo Finance • 17 days ago

Alkermes PLC (NASDAQ:ALKS) Surges 7.8% Pre-Market After Q2 2025 Earnings Beat Revenue and EPS Estimates

ALKERMES PLC (NASDAQ:ALKS [https://www.chartmill.com/stock/quote/ALKS]) reported second-quarter 2025 financial results that exceeded analyst expectations, driving a notable pre-market rally. The biopharmaceutical company posted revenue of... Full story

Yahoo Finance • 17 days ago

Alkermes Plc earnings beat by $0.16, revenue topped estimates

Investing.com - Alkermes Plc (NASDAQ: ALKS) reported second quarter EPS of $0.52, $0.16 better than the analyst estimate of $0.36. Revenue for the quarter came in at $390.7M versus the consensus estimate of $347.16M. Alkermes Plc’s stoc... Full story

Yahoo Finance • 17 days ago

S&P Futures Gain With Focus on U.S. JOLTs Report and Corporate Earnings, FOMC Meeting on Tap

September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.24% this morning, extending yesterday’s gains, while investors shift their focus from recent U.S. trade deals to economic data, a n... Full story

Yahoo Finance • 18 days ago

Here are the major earnings before the open Tuesday

Major earnings expected before the bell on Tuesday include: * The Boeing Company (BA [https://seekingalpha.com/symbol/BA]) * PayPal Holdings (PYPL [https://seekingalpha.com/symbol/PYPL]) * The Procter & Gamble Company (PG [https://s... Full story

Yahoo Finance • 18 days ago

Alkermes Q2 2025 Earnings Preview

* Alkermes (NASDAQ:ALKS [https://seekingalpha.com/symbol/ALKS]) is scheduled to announce Q2 earnings results on Tuesday, July 29th, before market open. * The consensus EPS Estimate is $0.38 [https://seekingalpha.com/symbol/ALKS/earning... Full story

Yahoo Finance • 25 days ago

Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.

Alkermes stock skidded Monday on the back of mixed results for its experimental narcolepsy treatment, an orexin agonist. Continue Reading View Comments... Full story

Yahoo Finance • 25 days ago

Stocks making the biggest moves midday: Block, SolarEdge, Cleveland-Cliffs, Verizon & more

Check out the companies making the biggest moves midday: Bruker — The lab instrument and tools maker shed 12% after the company issued weaker-than-expected guidance for the second quarter. The company expects to earn between 32 and 34 cent... Full story

Yahoo Finance • 25 days ago

Alkermes stock falls after BofA maintains Neutral rating on narcolepsy drug

Investing.com - Alkermes (NASDAQ:ALKS) shares fell Monday after BofA Securities maintained its Neutral rating and $35.00 price target following the company’s Phase 2 trial results for its narcolepsy treatment. According to InvestingPro dat... Full story

Yahoo Finance • 25 days ago

Alkermes narcolepsy drug shows positive results in phase 2 trial

DUBLIN - Alkermes plc (NASDAQ:ALKS), a pharmaceutical company with a market capitalization of $4.8 billion and an impressive 84% gross profit margin, announced Monday that its experimental narcolepsy treatment alixorexton demonstrated stat... Full story

Yahoo Finance • 29 days ago

BlackRock increases stake in Alkermes to 17.05%

DUBLIN - Investment management firm BlackRock (NYSE:BLK), Inc. has increased its stake in biopharmaceutical company Alkermes (NASDAQ:ALKS) PLC, according to a disclosure filed Thursday with the Irish Takeover Panel. BlackRock acquired 127... Full story

Yahoo Finance • last month

Deutsche Bank's top sector picks for Q3 ranked by their SA Quant ratings (part 1)

[The office building of CVS Health at its Corporate Headquarters at 1 CVS Dr, Woonsocket, RI, USA] JHVEPhoto Deutsche Bank this week updated its Fresh Money Quarterly list, spotlighting top investment ideas to hold over the next year in d... Full story

Yahoo Finance • 2 months ago

Stocks Tumble and Oil Surges on Middle East Jitters

The S&P 500 Index ($SPX) (SPY) Tuesday closed down -0.84%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.70%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -1.00%.  June E-mini S&P futures (ESM25) are down -0.86%, and J... Full story

Yahoo Finance • 2 months ago

Alkermes upgraded at UBS on prospects for sleep disorder therapy

[Wall Street sign, New York City, USA] mbbirdy/E+ via Getty Images UBS upgraded Alkermes (NASDAQ:ALKS [https://seekingalpha.com/symbol/ALKS]) to Buy from Neutral on Tuesday, citing prospects for Irish biotech’s orexin 2 receptor (OX2R) ag... Full story

Yahoo Finance • 2 months ago

Stocks Pressured by Middle East Tensions and Weak US Economic News

The S&P 500 Index ($SPX) (SPY) today is down -0.28%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.18%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.33%.  June E-mini S&P futures (ESM25) are down -0.30%, and June E-mini Nas... Full story

Yahoo Finance • 2 months ago

Stocks Fall as Chances Dim for an Early End to the Israel-Iran War

The S&P 500 Index ($SPX) (SPY) today is down -0.43%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.28%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.62%.  June E-mini S&P futures (ESM25) are down -0.42%, and June E-mini Nas... Full story

Yahoo Finance • 2 months ago

Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences

– Multiple Subgroup Analyses Presented From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan), Including Data on Lipid and Glycemic Profiles – DUBLIN, June 2, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced... Full story

Yahoo Finance • 3 months ago

Alkermes to Present New Research Related to ALKS 2680 at SLEEP 2025

– Company to Present Eight Posters and Two Oral Presentations, Including New Analyses From ALKS 2680 Phase 1 Study – – New Research Evaluating the Clinical, Economic and Humanistic Burden of Narcolepsy and Findings From In-Depth Qualitati... Full story

Yahoo Finance • 3 months ago

Alkermes plc (ALKS): Among Billionaire Jim Simons’ RenTech’s Small-Cap Stock Picks with Huge Upside Potential

We recently published a list of Billionaire Jim Simons’ RenTech’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Alkermes plc (NASDAQ:ALKS) stands against Billionaire Jim Simons’... Full story

Yahoo Finance • 6 months ago

Alkermes: Q4 Earnings Snapshot

DUBLIN (AP) — DUBLIN (AP) — Alkermes PLC (ALKS) on Wednesday reported fourth-quarter net income of $146.5 million. On a per-share basis, the Dublin-based company said it had net income of 88 cents. Earnings, adjusted for one-time gains an... Full story